2020 Cancer Grant

Recipients

previous recipients

Dr.

Alberto

Ciccia

2020

Associate Professor of Genetics & Development

Columbia University Irving Medical Center

Large-scale functional analysis of BRCA1/2 single nucleotide variants

Learn More

Dr.

Paul

Lambert

2020

Howard M. Temin Professor and Chair of Oncology

University of Wisconsin School of Medicine and Public Health

Role of the Microbiome in Cervical Cancer

Learn More

Dr.

Zhijie

Liu

2020

Assistant Professor, Molecular Medicine

The University of Texas Health Science Center at San Antonio

Targeting a non-canonical role of YAP/TEAD for breast cancer therapy

Learn More

Dr.

Liza

Makowski

2020

Professor, Department of Medicine

The University of Tennessee Health Science Center

PKC agonism reprograms innate immune suppression in Triple Negative Breast Cancer

Learn More

Dr.

Benjamin

Neel

2020

Professor, NYU Grossman School of Medicine/Director, Perlmutter Cancer Center

NYU Grossman School of Medicine

Genomics-Informed Organoid Platform for Rational Modeling of Ovarian Cancer Biology and Therapy.

Learn More

Dr.

Mark

Pegram

2020

Susy Yuan-Huey Hung Professor of Medical Oncology

Stanford University School of Medicine

Mechanisms of antibody-dependent cell-mediated cytotoxicity (ADCC) tolerance in HER2+ breast cancer

Learn More

Dr.

Richard

Wang

2020

Associate Professor, Dermatology

UT Southwestern Medical Center

Development of a novel marker for cervical cancer using HPV circular RNA

Learn More

Dr.

Karl

Willert

2020

Professor, Cellular & Molecular Medicine

University of California San Diego

Targeted Killing of FZD7-Positive Ovarian Tumors

Learn More

Dr.

Hua

Yu

2020

Associate Chair and Professor, Department of Immuno-Oncology

Beckman Research Institute of City of Hope

The opposing roles of PARP and PARG inhibitors in regulating ovarian cancer immune responses.

Learn More

Dr.

Hui

Zong

2020

Associate Professor, Microbiology, Immunology, & Cancer Biology

University of Virginia

Optimization of dosing regimen of PARP inhibitor for BRCA1-related breast cancer prevention.

Learn More
previous recipients
homecausesgiveeventsblog
donate now